(HLN) Haleon - Performance 23.4% in 12m
Compare HLN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
52.55%
#11 in Group
Rel. Strength
78.09%
#1675 in Universe
Total Return 12m
23.35%
#31 in Group
Total Return 5y
39.66%
#33 in Group
P/E 25.6
65th Percentile in Group
P/E Forward 20.9
67th Percentile in Group
PEG 1.85
87th Percentile in Group
FCF Yield 4.69%
88th Percentile in Group
12m Total Return: HLN (23.4%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: HLN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HLN
Total Return (including Dividends) | HLN | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.97% | -5.85% | -3.01% |
3 Months | 7.63% | -11.95% | -3.15% |
12 Months | 23.35% | -11.00% | 10.19% |
5 Years | 39.66% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | HLN | XBI | S&P 500 |
1 Month | -65.5% | -59.8% | -5.5% |
3 Months | 85.3% | -70.5% | -58.4% |
12 Months | 67.6% | -6.9% | 84.1% |
5 Years | 88.1% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #67 | 1.99% | -0.99% |
3 Month | #29 | 22.2% | 11.1% |
12 Month | #30 | 38.6% | 12.0% |
5 Years | #36 | 38.0% | -9.17% |
FAQs
Does HLN Haleon outperforms the market?
Yes,
over the last 12 months HLN made 23.35%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months HLN made 7.63%, while XBI made -11.95%.
Over the last 3 months HLN made 7.63%, while XBI made -11.95%.
Performance Comparison HLN vs Indeces and Sectors
HLN vs. Indices HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.81% | -0.96% | -3.48% | 13.2% |
US NASDAQ 100 | QQQ | 2.79% | 0.09% | -2.71% | 14.8% |
US Dow Jones Industrial 30 | DIA | 1.61% | -1.83% | -4.40% | 13.8% |
German DAX 40 | DAX | 3.11% | -0.59% | -20.3% | 1.66% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.10% | -4.20% | 11.8% | 14.2% |
Hongkong Hang Seng | HSI | -0.16% | -6.74% | 5.74% | 6.02% |
India NIFTY 50 | INDA | 0.78% | -11.8% | 6.87% | 22.7% |
Brasil Bovespa | EWZ | 1.70% | -12.3% | 4.52% | 35.1% |
HLN vs. Sectors HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.35% | -0.16% | -11.6% | 4.14% |
Consumer Discretionary | XLY | 1.05% | -0.14% | -6.84% | 9.29% |
Consumer Staples | XLP | -0.98% | -2.13% | -4.32% | 12.3% |
Energy | XLE | 0.72% | -12.0% | -9.06% | 22.5% |
Financial | XLF | 1.33% | -1.27% | -15.6% | 1.10% |
Health Care | XLV | 1.39% | -0.81% | 1.22% | 21.7% |
Industrial | XLI | 1.50% | -3.28% | -2.77% | 14.8% |
Materials | XLB | 0.71% | -4.48% | 4.63% | 27.3% |
Real Estate | XLRE | -0.23% | -1.28% | -0.36% | 9.99% |
Technology | XLK | 2.94% | 0.04% | 1.64% | 21.3% |
Utilities | XLU | -1.48% | -4.79% | -2.60% | -1.88% |
Aerospace & Defense | XAR | 2.41% | -5.25% | -7.40% | 2.42% |
Biotech | XBI | 6.37% | 1.88% | 14.2% | 34.4% |
Homebuilder | XHB | 1.31% | -4.12% | 15.9% | 31.1% |
Retail | XRT | -0.49% | -3.47% | 0.60% | 28.1% |